Truist Financial Corp Haemonetics Corp Transaction History

Truist Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$80.59 - $92.61 $11,846 - $13,613	-147 Reduced 3.92%	3,603 $308,000
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $68,442 - $77,503	-829 Reduced 18.1%	3,750 $335,000
Q2 2023 Aug 01, 2023	SELL	$80.84 - $89.45 $92,642 - $102,509	-1,146 Reduced 20.02%	4,579 $389,000
Q1 2023 May 05, 2023	BUY	$72.75 - $90.6 $416,493 - $518,684	5,725 New	5,725 $473,000
Q1 2021 May 17, 2021	SELL	$111.01 - $139.48 $203,814 - $256,085	-1,836 Closed	0 $0
Q4 2020 Nov 19, 2021	SELL	$88.75 - $119.95 $181,760 - $245,657	-2,048 Reduced 52.73%	1,836 $218,000
Q4 2020 Feb 18, 2021	BUY	$88.75 - $119.95 $344,705 - $465,885	3,884 New	3,884 $461,000

333

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.